Buminate 25% Related Published Studies
Well-designed clinical trials related to Buminate 25% (Albumin)
Glycated albumin predicts the effect of dual and single antiplatelet therapy on
recurrent stroke. [2015]
Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation
end-products, and blood pressure in diabetic nephropathy. [2013]
High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a
randomised, double-blind, phase 3, placebo-controlled trial. [2013]
Albumin resuscitation for traumatic brain injury: is intracranial hypertension
the cause of increased mortality? [2013]
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. [2011.11]
Pioglitazone delays proximal tubule dysfunction and improves cerebral vessel endothelial dysfunction in normoalbuminuric people with type 2 diabetes mellitus. [2011.10]
Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study. [2011.07]
Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria:Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT). [2011.06]
The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. [2011.06]
High normal levels of albuminuria and risk of hypertension in Indo-Asian population. [2011.05.17]
Co-administration of albumin-furosemide in patients with the nephrotic syndrome. [2011.05]
Long-term effects of Irbesartan treatment and smoking on nucleic acid oxidation in patients with type 2 diabetes and microalbuminuria: an Irbesartan in patients with type 2 diabetes and Microalbuminuria (IRMA 2) substudy. [2011.05]
Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients. [2011.05]
Aliskiren in combination with losartan reduces albuminuria independent of baseline blood pressure in patients with type 2 diabetes and nephropathy. [2011.05]
Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy. [2011.04]
Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. [2011.03.14]
The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. [2011.02]
Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial. [2011.02]
Effect of chronic regular exercise on serum ischemia-modified albumin levels and oxidative stress in type 2 diabetes mellitus. [2011]
Metabolic effects of albumin therapy in acute lung injury measured by proton
nuclear magnetic resonance spectroscopy of plasma: a pilot study. [2011]
The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. [2011]
Long-term effects of Irbesartan treatment and smoking on nucleic acid oxidation
in patients with type 2 diabetes and microalbuminuria: an Irbesartan in patients
with type 2 diabetes and Microalbuminuria (IRMA 2) substudy. [2011]
Office and ambulatory pulse pressure--association with clinical characteristics
and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes
(ROADMAP study). [2011]
Pre-exchange 5% Albumin Infusion in Low Birth Weight Neonates with Intensive Phototherapy Failure--A Randomized Controlled Trial. [2010.09.07]
Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. [2010.08]
Rationale and design of the Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect (EVALUATE) trial: a double-blinded randomized placebo-controlled trial to evaluate the antialbuminuric effects of an aldosterone blocker in hypertensive patients with albuminuria. [2010.06]
Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. [2010.05.27]
99m Tc-albumin nanocolloid joint scintigraphy in rheumatoid arthritis patients who are in clinical remission - is remission real ? [2010.05]
Platelet-rich fibrin versus albumin in surgical wound repair: a randomized trial with paired design. [2010.05]
Lipoprotein profile, plasma ischemia modified albumin and LDL density change in the course of postprandial lipemia. Insights from the LIPGENE study. [2010.04.19]
[Human Albumin Grifols 5% in plasmapheresis: a new therapy involving beta-amyloid mobilisation in Alzheimer's disease] [2010.03.16]
Dual blockade of the renin-angiotensin-aldosterone system is safe and effective in reducing albuminuria in Asian type 2 diabetic patients with nephropathy. [2010.02]
Ischemia-modified albumin reduction after coronary bypass surgery is associated with the cardioprotective efficacy of cold-blood cardioplegia enriched with N-acetylcysteine: a preliminary study. [2010]
Anti-glycation and anti-albuminuric effects of GLY-230 in human diabetes. [2010]
Human albumin for intradialytic hypotension in haemodialysis patients. [2010]
[Human Albumin Grifols 5% in plasmapheresis: a new therapy involving beta-amyloid
mobilisation in Alzheimer's disease]. [Article in Spanish] [2010]
Serum albumin concentration: a predictive factor of infliximab pharmacokinetics
and clinical response in patients with ulcerative colitis. [2010]
Effects of saline or albumin resuscitation on standard coagulation tests. [2009.12]
Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. [2009.12]
Therapeutic influence of 20 % albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial. [2009.11]
Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. [2009.09]
Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials. [2009.07.07]
Time-dependent variations in ischemia-modified albumin levels in mesenteric ischemia. [2009.06]
Albumin versus normal saline for dehydrated term infants with metabolic acidosis due to acute diarrhea. [2009.06]
Effect of Albumin Administration Prior to Exchange Transfusion in Term Neonates with Hyperbilirubinemia A Randomized Controlled Trial. [2009.05.20]
Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial. [2009.05]
A breakfast with alpha-lactalbumin, gelatin, or gelatin + TRP lowers energy intake at lunch compared with a breakfast with casein, soy, whey, or whey-GMP. [2009.04]
The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial. [2009.04]
A randomized controlled study of human serum albumin and serum substitute supplement as protein supplements for IVF culture and the effect on live birth rates. [2009.04]
Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome. [2009.04]
Effect of megestrol acetate on serum albumin level in malnourished dialysis patients. [2009.03]
Avosentan reduces albumin excretion in diabetics with macroalbuminuria. [2009.03]
A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma. [2009.02]
Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4. [2009.02]
The Effects of Dietary Patterns on Urinary Albumin Excretion: Results of the Dietary Approaches to Stop Hypertension (DASH) Trial. [2009.01.22]
A randomized controlled study of human serum albumin and serum substitute supplement as protein supplements for IVF culture and the effect on live birth rates. [2009.01.14]
The natural course of microalbuminuria among African Americans with type 2 diabetes: a 3-year study. [2009.01]
Ingested protein dose response of muscle and albumin protein synthesis after resistance exercise in young men. [2009.01]
Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial. [2009]
Is albumin administration beneficial in early stage of postoperative hypoalbuminemia following gastrointestinal surgery?: a prospective randomized controlled trial. [2008.11]
Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study. [2008.11]
Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis. [2008.09]
Long-term effect of a chicken-based diet versus enalapril on albuminuria in type 2 diabetic patients with microalbuminuria. [2008.09]
Effect of different albumin concentrations in extracorporeal circuit prime on perioperative fluid status in young children. [2008.09]
Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the VALERIA trial. [2008.09]
Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension. [2008.09]
Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. [2008.08]
Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study. [2008.08]
Is albumin administration beneficial in early stage of postoperative hypoalbuminemia following gastrointestinal surgery?: a prospective randomized controlled trial. [2008.07.22]
Recombinant human growth hormone increases albumin and prolongs survival in patients with chronic liver failure: a pilot open, randomized, and controlled clinical trial. [2008.07]
Effect of maternal egg consumption on breast milk ovalbumin concentration. [2008.07]
Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study. [2008.06]
Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. [2008.06]
HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial. [2008.06]
An alpha-adrenergic blocker titrated by self-measured blood pressure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: the Japan Morning Surge-1 Study. [2008.06]
Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria. [2008.06]
Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: a double blind, randomized, placebo-controlled, cross-over trial. [2008.06]
Usefulness of bilirubin/ albumin ratio for predicting bilirubin-induced neurotoxicity in premature infants. [2008.05.01]
Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. [2008.05]
Telemedicine home blood pressure measurements and progression of albuminuria in elderly people with diabetes. [2008.05]
Effects of strict blood pressure control by a long-acting calcium channel blocker on brain natriuretic peptide and urinary albumin excretion rate in Japanese hypertensive patients. [2008.05]
The evidence for small-volume resuscitation with hyperoncotic albumin in critical illness. [2008.04.30]
Effects of alpha-lactalbumin-enriched formula containing different concentrations of glycomacropeptide on infant nutrition. [2008.04]
Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study. [2008.04]
Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. [2008.03.19]
HES 130/0.4 (Voluven(R)) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial. [2008.03.13]
Infusion of albumin attenuates changes in serum protein binding of drugs in surgical patients compared with volume replacement with HAES. [2008.03]
Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetes. [2008.03]
Combination of the Electrocardiographic Strain Pattern and Albuminuria for the Prediction of New-onset Heart Failure in Hypertensive Patients: The LIFE Study. [2008.03]
A comparison of albumin-bolus therapy versus normal saline-bolus therapy for hypotension in neonates. [2008.01]
Serum transforming growth factor-beta 1 levels in normoalbuminuric and normotensive patients with type 2 diabetes. Effect of metformin and rosiglitazone. [2008.01]
The evidence for small-volume resuscitation with hyperoncotic albumin in critical illness. [2008]
Haemodynamics and acid-base equilibrium after cardiac surgery: comparison of rapidly degradable hydroxyethyl starch solutions and albumin. [2008]
Recombinant human growth hormone increases albumin and prolongs survival in patients with chronic liver failure: A pilot open, randomized, and controlled clinical trial. [2007.12.27]
Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. [2007.12]
Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. [2007.12]
Plasma matrix metalloproteinase-9 and ACE-inhibitor-induced improvement of urinary albumin excretion in non-diabetic, microalbuminuric subjects. [2007.12]
Rosiglitazone decreases albuminuria in type 2 diabetic patients. [2007.12]
Role of albumin coating of tympanostomy tubes: long-term clinical evaluation. [2007.12]
Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy. [2007.11]
Miglitol increases the adiponectin level and decreases urinary albumin excretion in patients with type 2 diabetes mellitus. [2007.11]
|
